LifeVantage Co. (NASDAQ:LFVN - Get Free Report) declared a quarterly dividend on Tuesday, October 29th, Zacks reports. Shareholders of record on Monday, December 2nd will be given a dividend of 0.04 per share on Monday, December 16th. This represents a $0.16 dividend on an annualized basis and a yield of 1.31%. The ex-dividend date of this dividend is Monday, December 2nd.
LifeVantage has a dividend payout ratio of 22.2% indicating that its dividend is sufficiently covered by earnings.
LifeVantage Stock Down 5.5 %
Shares of LFVN stock traded down $0.71 during trading hours on Thursday, hitting $12.22. 77,354 shares of the company were exchanged, compared to its average volume of 60,403. The firm has a market cap of $155.21 million, a PE ratio of 43.64 and a beta of 0.84. LifeVantage has a 1 year low of $4.20 and a 1 year high of $14.71. The firm has a fifty day moving average of $10.94 and a 200 day moving average of $8.37.
LifeVantage (NASDAQ:LFVN - Get Free Report) last announced its quarterly earnings data on Tuesday, October 29th. The company reported $0.15 earnings per share for the quarter, hitting the consensus estimate of $0.15. The business had revenue of $47.21 million for the quarter. LifeVantage had a net margin of 1.47% and a return on equity of 27.85%.
About LifeVantage
(
Get Free Report)
LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.
Further Reading
Before you consider LifeVantage, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and LifeVantage wasn't on the list.
While LifeVantage currently has a "hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
